Leveraging a deep understanding of technology and healthcare, this venture capital firm has built a robust portfolio across various stages of investment, particularly in early and growth rounds. With a solid track record of over 200 deals, they have achieved notable exits in the U.S. and global markets, emphasizing a data-driven, thematic approach. Their strategic style combines operator-first insights with a keen eye for disruptive innovation, consistently identifying opportunities in emerging sectors. Focused on fostering long-term partnerships, they prioritize companies that demonstrate transformative potential in their respective industries.